THCTenet Healthcare Corp.

BKD's Q2 weighted average occupancy rises to 82.4% as steady resident demand and RevPAR growth expectations set the stage for its upcoming earnings.

U.S.-Iran tensions likely to lift demand for defensive plays, with Tenet Healthcare, Elevance Health and Aveanna Healthcare standing out as cheap medical stocks.

Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

HCA is expanding hospitals, ERs and outpatient sites while investing billions in new capacity to support future healthcare demand and long-term growth.

THC is gaining on rising admissions, strong ambulatory care growth and earnings momentum. But can it sustain gains as expenses keep climbing?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Based on the average brokerage recommendation (ABR), Tenet (THC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

In trading on Thursday, shares of Tenet Healthcare Corp. (Symbol: THC) crossed above their 200 day moving average of $198.48, changing hands as high as $208.52 per share. Tenet Healthcare Corp. shares are currently trading up about 6.7% on the day. The chart below shows the on...